Found 227 matching trials
Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) PHASE3 The purpose of this trial is to investigate the efficacy of cetuximab in co...
Show More Learn More & Join Trial
Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC PHASE2 The main purpose of the study was to investigate the clinical activity and ...
Show More Location
Semmelweis Egyetem - Pulmonologiai Klinika
Learn More & Join Trial
Study in Advanced Solid Tumors PHASE2 The primary purpose of this study is to help answer the following research ...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N PHASE2 The main objective of this research is to increase the life expectancy of p...
Show More Location
Institut de Cancérologie de Lorraine
Learn More & Join Trial
Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC) PHASE2 The aim of the study is to investigate the efficacy and safety of cetuximab...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma. PHASE2 Multicenter, open phase 2 study on patients with malignant mesothelioma. St...
Show More Learn More & Join Trial
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer PHASE1 RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...
Show More Location
Baylor Research Institute
Learn More & Join Trial
C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck PHASE1 The purpose of this research study is to determine the safest and most effe...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
BBO-11818 in Adult Subjects With KRAS Mutant Cancer PHASE1 A first in human study to evaluate the safety and preliminary antitumor act...
Show More Location
The Angeles Clinic and Research Institute - West Los Angeles Office
Learn More & Join Trial
Cetuximab + Tislelizumab + Chemotherapy in the Treatment of Unresectable LA HNSCC PHASE2 This prospective, single-arm, Phase II study aims to evaluate the efficacy,...
Show More Location
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Learn More & Join Trial